Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual
disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
Am J Clin Pathol. 2024 Apr 20:aqae034. doi: 10.1093.
PubMed
Abstract available
Lower relapse incidence with haploidentical versus matched sibling or unrelated
donor hematopoietic cell transplantation for core-binding factor AML patients in
CR2: A study from the Global Committee and the Acute Leukemia Working Party of
the Europea
Am J Hematol. 2024 Apr 24. doi: 10.1002/ajh.27342.
PubMed
Abstract available
Identification of the characteristics and prognostic impact of FUS::ERG and
RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
Am J Hematol. 2024 Apr 23. doi: 10.1002/ajh.27340.
PubMed
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update
on diagnosis, genetics, risk stratification, and management.
Am J Hematol. 2024 Apr 21. doi: 10.1002/ajh.27321.
PubMed
Abstract available
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem
cell transplantation is a risk factor for death in patients with myelodysplastic
syndrome or chronic myelomonocytic leukemia.
Ann Hematol. 2024 Apr 25. doi: 10.1007/s00277-024-05772.
PubMed
Abstract available
Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco.
Ann Hematol. 2024 Apr 24. doi: 10.1007/s00277-024-05747.
PubMed
Abstract available
Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic
Hematopoietic Cell Transplantation.
Blood. 2024 Apr 26:blood.2023022697. doi: 10.1182/blood.2023022697.
PubMed
Abstract available
T cells take aim in AML: targeting IDH2.
Blood. 2024;143:1681-1682.
PubMed
How I Treat Philadelphia Chromosome-like Acute Lymphoblastic Leukemia in
Children, Adolescents, and Young Adults.
Blood. 2024 Apr 24:blood.2023023153. doi: 10.1182/blood.2023023153.
PubMed
Abstract available
Prediction of outcomes for high-count monoclonal B lymphocytosis using an
epigenetic and immunogenetic signature.
Blood. 2024;143:1752-1757.
PubMed
Abstract available
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic
myeloid leukemia patients at presentation at a tertiary care teaching hospital in
Addis Ababa, Ethiopia: a cross-sectional study.
BMC Cancer. 2024;24:530.
PubMed
Abstract available
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid
leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.
BMC Cancer. 2024;24:520.
PubMed
Abstract available
Long-term remission in a patient with relapsed Richter's transformation treated
with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell
transplantation.
Eur J Haematol. 2024;112:984-987.
PubMed
Abstract available
Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results
from the German multicentre REALITY study.
Eur J Haematol. 2024;112:927-937.
PubMed
Abstract available
Pancreas-related persisting sequelae in ALL survivors with a history of
asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Eur J Haematol. 2024;112:944-956.
PubMed
Abstract available
Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia
patients.
Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14213.
PubMed
Abstract available
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia
relapsing after hematopoietic stem cell transplantation.
Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14217.
PubMed
Abstract available
Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy
in pediatric patients with relapsed/refractory leukemia.
Eur J Haematol. 2024 Apr 24. doi: 10.1111/ejh.14216.
PubMed
Abstract available
A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in
myelodysplastic syndromes and acute myeloid leukemias.
Genes Chromosomes Cancer. 2024;63:e23235.
PubMed
Abstract available
CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve
Survival in Children Relapsed/Refractory Philadelphia Chromosome-positive B-cell
Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2024 Apr 23. doi: 10.1097/MPH.0000000000002861.
PubMed
Abstract available
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic
phase chronic myeloid leukemia.
Leuk Lymphoma. 2024 Apr 23:1-6. doi: 10.1080/10428194.2024.2343758.
PubMed
Abstract available
Challenges in management of older patients with chronic myeloid leukemia.
Leuk Lymphoma. 2024 Apr 23:1-14. doi: 10.1080/10428194.2024.2342559.
PubMed
Abstract available
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients
with FLT3-mutant acute myeloid leukemia.
Leuk Lymphoma. 2024 Apr 22:1-9. doi: 10.1080/10428194.2024.2344052.
PubMed
Abstract available
Evaluation of safety outcomes with transitioning obinutuzumab from standard rate
to short duration infusion in patients with chronic lymphocytic leukemia.
Leuk Lymphoma. 2024 Apr 22:1-2. doi: 10.1080/10428194.2024.2341999.
PubMed
Pairing obinutuzumab with venetoclax in relapsed CLL.
Leuk Lymphoma. 2024;65:543-545.
PubMed
Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive
molecular data available.
Leuk Lymphoma. 2024;65:700-703.
PubMed
Effects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive
cells.
Leuk Lymphoma. 2024;65:696-699.
PubMed
The CIpP activator, TR-57, is highly effective as a single agent and in
combination with venetoclax against CLL cells in vitro.
Leuk Lymphoma. 2024;65:585-597.
PubMed
Abstract available
8-Cl-Ado and 8-NH(2)-Ado synergize with venetoclax to target the
methionine-MAT2A-SAM axis in acute myeloid leukemia.
Leukemia. 2024 Apr 20. doi: 10.1038/s41375-024-02222.
PubMed
Abstract available
CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
N Engl J Med. 2024;390:1526-1527.
PubMed
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
N Engl J Med. 2024;390:1467-1480.
PubMed
Abstract available
Thank you for your interest in scientific medicine.